Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders

Frontiers in Microbiology

Volumn 2, Issue JAN, 2012, Pages

  Shoji, Ikuo ^a   Deng, Lin ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetes; Fox01; Gluconeogenesis; GLUT2; HCV; JNK; NS5A

Indexed keywords

HEPATITIS C VIRUS;

EID: 84867141784     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00278     Document Type: Review

References (37)

1. Banerjee, A., Meyer, K., Mazumdar, B., Ray, R. B., and Ray, R. (2010). Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J. Virol. 84, 5936-5946.
2. Bungyoku, Y., Shoji, I., Makine, T., Adachi, T., Hayashida, K., Nagano-Fujii, M., Ide, Y. H., Deng, L., and Hotta, H. (2009). Efficient production of infectious hepatitis C virus with adaptive mutations in cultured hepatoma cells. J. Gen. Virol. 90,1681-1691.
3. Burdette, D., Olivarez, M., and Waris, G. (2010). Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. J. Gen. Virol. 91,681-690.
4. Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby,R., Barr, P. J., Weiner, A. J., Bredley, D. W., Kuo, G., and Houghton, M. (1991). Genetic organization and diversity of the hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 88, 2451-2455.
5. Clore, J. N., Stillman, J., and Sugerman, H. (2000). Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 49, 969-974.
6. Deng, L., Adachi, T., Kitayama, K., Bungyoku, Y., Kitazawa, S., Ishido, S., Shoji, I., and Hotta, H. (2008). Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway. J. Virol. 82, 10375-10385.
7. Deng, L., Shoji, I., Ogawa, W., Kaneda, S., Soga, T., Jiang, D. P., Ide, Y. H., and Hotta, H. (2011). Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J. Virol. 85, 8556-8568.
8. Dionisio, N., Garcia-Mediavilla, M. V., Sanchez-Campos, S., Majano, P. L., Benedicto, I., Rosado, J. A., Salido, G. M., and Gonzalez-Gallego, J. (2009). Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes. J. Hepatol. 50, 872-882.
9. Godoy, A., Ulloa, V., Rodriguez, F., Reinicke, K., Yanez, A. J., Garcia Mde, L., Medina, R. A., Carrasco, M., Barberis, S., Castro, T., Martinez, F., Koch, X., Vera, J. C., Poblete, M. T., Figueroa, C. D., Peruzzo, B., Perez,F., and Nualart, E (2006). Differential subcellular distribution of glucose transporters GLUT 1-6 and GLUT9 in human cancer: ultrastructural localization of GLUT1 and GLUT5 in breast tumor tissues. J. Cell. Physiol. 207, 614-627.
10. Gross, D. N., van den Heuvel, A. P., and Birnbaum, M. J. (2008). The role of FoxO in the regulation of metabolism. Oncogene 27, 2320-2336.
11. Hirota, K., Sakamaki, J., Ishida, J., Shimamoto, Y., Nishihara, S., Kodama, N., Ohta, K., Yamamoto, M., Tanimoto, K., and Fukamizu, A. (2008). A combination of HNF-4 and Foxo 1 is required for reciprocal transcriptional regulation of glucokinase and glucose-6-phosphatase genes in response to fasting and feeding. J. Biol. Chem. 283, 32432-32441.
12. Karpac, J., and Jasper, H. (2009). Insulin and JNK: optimizing metabolic homeostasis and lifespan. Trends Endocrinol. Metab. 20, 100-106.
13. Kasai, D., Adachi, T., Deng, L., Nagano-Fujii, M., Sada, K., Ikeda, M., Kato, N., Ide, Y H., Shoji, I., and Hotta, H. (2009). HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters. J. Hepatol. 50, 883-894.
14. Kawaguchi, T., Yoshida, T., Harada, M., Hisamoto, T., Nagao, Y., Ide, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., Baba, S., Koga, H., Kumashiro, R., Ueno, T., Ogata, H., Yoshimura, A., and Sata, M. (2004). Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am.J. Pathol. 165, 1499-1508.
15. Koike, K. (2007). Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J. Gastroenterol. Hepatol. 22(Suppl. 1), S108-S111.
16. Lemon, S. M., Walker, C., Alter, M. J., and Yi, M. (2007). Hepatitis C virus, in Fields Virology, 5th Edn, eds B. N. Fields, D. M. Knipe, and P. M. Howley (Philadelphia, PA: Wolters Kluwer Health/Lippincott Williams and Wilkins), 1291-1304.
17. Leturque, A., Brot-Laroche, E., and Le Gall, M. (2009). GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am. J. Physiol. Endocrinol. Metab. 296, E985-E992.
18. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., and Rice, C. M. (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
19. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., and Barten-schlager, R. (1999). Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113.
20. Macheda, M. L., Rogers, S., and Best, J. D. (2005). Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 202, 654-662.
21. Mason, A. L., Lau, J. Y., Hoang, N., Qian, K., Alexander, G. J., Xu, L., Guo, L., Jacob, S., Regenstein, E G., Zimmerman, R., Everhart, J. E., Wasser-fall, C., Maclaren, N. K., and Perrillo,R. P. (1999). Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 29, 328-333.
22. Miyamoto, H., Moriishi, K., Moriya, K., Murata, S., Tanaka, K., Suzuki, T., Miyamura, T., Koike, K., and Matsuura, Y (2007). Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J. Virol. 81, 1727-1735.
23. Nakashima, K., Takeuchi, K., Chihara, K., Hotta, H., and Sada, K. (2011). Inhibition of hepatitis C virus replication through adenosine monophosphate-activated protein kinase-dependent and-independent pathways. Microbiol. Immunol. 55, 774-782.
24. Negro, F. (2011). Mechanisms of hepatitis C virus-related insulin resistance. Clin. Res. Hepatol. Gastroenterol. 35, 358-363.
25. Negro, F., and Alaei, M. (2009). Hepatitis C virus and type 2 diabetes. World I Gastroenterol. 15, 1537-1547.
26. Nomura-Takigawa, Y., Nagano-Fujii, M., Deng, L., Kitazawa, S., Ishido, S., Sada, K., and Hotta, H. (2006). Non-structural protein 4A of Hepatitis C virus accumulates on mitochondria and renders the cells prone to undergoing mitochondria-mediated apoptosis.J. Gen. Virol. 87, 1935-1945.
27. Pazienza, V., Clement, S., Pugnale, P., Conzelman, S., Foti, M., Mangia, A., and Negro, E (2007). The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms. Hepatology 45, 1164-1171.
28. Poynard, T., Yuen, M. F., Ratziu, V., and Lai, C. L. (2003). Viral hepatitis C. Lancet 362,2095-2100.
29. Rozance, P. J., Limesand, S. W., Barry, J. S., Brown, L. D., Thorn, S. R., LoTurco, D., Regnault, T. R., Friedman, J. E. and Hay, W. W. Jr. (2008). Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep. Am. J. Physiol. Endocrinol. Metab. 294, E365-E370.
30. Shintani, Y., Fujie, H., Miyoshi, H., Tsutsumi, T., Tsukamoto, K., Kimura, S., Moriya, K., and Koike, K. (2004). Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 126, 840-848.
31. Takashima, M., Ogawa, W., Hayashi, K., Inoue, H., Kinoshita, S., Okamoto, Y., Sakaue, H., Wataoka, Y., Emi, A., Senga, Y., Matsuki, Y., Watanabe, E., Hiramatsu, R., and Kasuga, M. (2010). Role of KLF15 in regulation of hepatic gluconeogenesis and metformin action. Diabetes 59, 1608-1615.
32. Tzivion, G., Dobson, M., and Ramakrishnan, G. (2011). FoxO transcription factors; Regulation by AKT and 14-3-3 proteins. Biochim. Biophys. Acta 1813, 1938-1945.
33. van der Horst, A., and Burgering, B. M. (2007). Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8, 440-450.
34. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G., Mizokami, M., Barten-schlager, R., and Liang, T. J. (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796.
35. Wang, A. G., Lee, D. S., Moon, H. B., Kim, J. M., Cho, K. H., Choi, S. H., Ha, H. L., Han, Y H., Kim, D. G., Hwang, S. B., and Yu, D. Y. (2009). Non-structural 5A protein of hepatitis C virus induces a range of liver pathology in transgenic mice. J. Pathol. 219,253-262.
36. Wu, X., and Freeze, H. H. (2002). GLUT14, a duplicon of GLUT3, is specifically expressed in testis as alternative splice forms. Genomics 80,553-557.
37. Zhao, X., Gan, L., Pan, H., Kan, D., Majeski, M., Adam, S. A., and Unterman, T. G. (2004). Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation-and 14-3-3-dependent and-independent mechanisms. Biochem. J. 378, 839-849.